Login / Signup

Fulminant Diabetes in a Patient with Advanced Melanoma on Nivolumab.

Nora ChokrHafsa FarooqElizabeth Guadalupe
Published in: Case reports in oncological medicine (2018)
Anti-PD-1 immunotherapy is effective in cancers refractory to standard chemotherapy. These agents can precipitate autoimmune disorders. As the use of anti-PD-1 agents is expected to rise, physicians should be educated about the potential side effects. We recommend conducting routine blood glucose checks in patients on these agents.
Keyphrases